Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis (NORSTENT)
Comparison of the Long-term Effects on Mortality and Cardiovascular Morbidity of Percutaneous Coronary Intervention With Drug-eluting Stent Versus Bare-metal Stent. Randomized, Five-year Prospective, Multicenter Clinical Trial
Sponsor: Norwegian Council on Cardiovascular diseases
Listed as NCT00811772, this NA trial focuses on Angina Pectoris and Coronary Atherosclerosis and remains completed. Sponsored by Norwegian Council on Cardiovascular diseases, it has been updated 7 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE4 → NA
-
Jun 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE4
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Norwegian Council on Cardiovascular diseases
- The Research Council of Norway
- The Royal Norwegian Ministry of Health
- University of Tromso
For direct contact, visit the study record on ClinicalTrials.gov .